Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 3
2011 2
2012 3
2013 2
2014 2
2015 6
2016 3
2017 2
2018 4
2019 5
2020 3
2021 9
2022 10
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways.
Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabothu S, Izmirly P, Clancy R, Belmont HM, Koenigsberg M, Mokrzycki M, Rominieki H, Graham JA, Rocca JP, Bornkamp N, Jordan N, Schulte E, Wu M, Pullman J, Slowikowski K, Raychaudhuri S, Guthridge J, James J, Buyon J, Tuschl T, Putterman C; Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium. Der E, et al. Among authors: goilav b. Nat Immunol. 2019 Jul;20(7):915-927. doi: 10.1038/s41590-019-0386-1. Epub 2019 May 20. Nat Immunol. 2019. PMID: 31110316 Free PMC article.
Biomarkers for CNS involvement in pediatric lupus.
Rubinstein TB, Putterman C, Goilav B. Rubinstein TB, et al. Among authors: goilav b. Biomark Med. 2015;9(6):545-58. doi: 10.2217/bmm.15.26. Biomark Med. 2015. PMID: 26079959 Free PMC article. Review.
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership.
Carlucci PM, Li J, Fava A, Deonaraine KK, Wofsy D, James JA, Putterman C, Diamond B, Davidson A, Fine DM, Monroy-Trujillo J, Atta MG, DeJager W, Guthridge JM, Haag K, Rao DA, Brenner MB, Lederer JA, Apruzzese W, Belmont HM, Izmirly PM, Zaminski D, Wu M, Connery S, Payan-Schober F, Furie R, Dall'Era M, Cho K, Kamen D, Kalunian K, Anolik J, Barnas J, Ishimori M, Weisman MH; Accelerating Medicines Partnership (AMP) RA/SLE Network; Buyon JP, Petri M. Carlucci PM, et al. Rheumatology (Oxford). 2022 Nov 2;61(11):4335-4343. doi: 10.1093/rheumatology/keac067. Rheumatology (Oxford). 2022. PMID: 35212719 Free PMC article.
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS).
Smith EMD, Aggarwal A, Ainsworth J, Al-Abadi E, Avcin T, Bortey L, Burnham J, Ciurtin C, Hedrich CM, Kamphuis S, Lambert L, Levy DM, Lewandowski L, Maxwell N, Morand E, Ozen S, Pain CE, Ravelli A, Saad Magalhaes C, Pilkington C, Schonenberg-Meinema D, Scott C, Tullus K, Beresford MW; International cSLE T2T Task Force. Smith EMD, et al. Clin Immunol. 2023 May;250:109296. doi: 10.1016/j.clim.2023.109296. Epub 2023 Mar 17. Clin Immunol. 2023. PMID: 36934849 Free PMC article.
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.
Chalhoub NE, Wenderfer SE, Levy DM, Rouster-Stevens K, Aggarwal A, Savani SI, Ruth NM, Arkachaisri T, Qiu T, Merritt A, Onel K, Goilav B, Khubchandani RP, Deng J, Fonseca AR, Ardoin SP, Ciurtin C, Kasapcopur O, Jelusic M, Huber AM, Ozen S, Klein-Gitelman MS, Appenzeller S, Cavalcanti A, Fotis L, Lim SC, Silva RM, Miramontes JR, Rosenwasser NL, Saad-Magalhaes C, Schonenberg-Meinema D, Scott C, Silva CA, Enciso S, Terreri MT, Torres-Jimenez AR, Trachana M, Al-Mayouf SM, Devarajan P, Huang B, Brunner HI; Childhood Arthritis and Rheumatology Research Alliance Lupus Nephritis Work Group and the Pediatric Rheumatology European Society Lupus Working Party. Chalhoub NE, et al. Among authors: goilav b. Arthritis Rheumatol. 2022 Feb;74(2):263-273. doi: 10.1002/art.41930. Epub 2022 Jan 4. Arthritis Rheumatol. 2022. PMID: 34279063 Free PMC article.
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus.
Holland MJ, Beresford MW, Feldman BM, Huggins J, Norambuena X, Silva CA, Susic G, Sztajnbok F, Uziel Y, Appenzeller S, Ardoin SP, Avcin T, Flores F, Goilav B, Khubchandani R, Klein-Gitelman M, Levy D, Ravelli A, Wenderfer SE, Ying J, Ruperto N, Brunner HI; PRINTO and PRCSG Investigators. Holland MJ, et al. Among authors: goilav b. Arthritis Care Res (Hoboken). 2018 Nov;70(11):1621-1629. doi: 10.1002/acr.23531. Arthritis Care Res (Hoboken). 2018. PMID: 29409150
The pathogenesis, diagnosis and treatment of lupus nephritis.
Schwartz N, Goilav B, Putterman C. Schwartz N, et al. Among authors: goilav b. Curr Opin Rheumatol. 2014 Sep;26(5):502-9. doi: 10.1097/BOR.0000000000000089. Curr Opin Rheumatol. 2014. PMID: 25014039 Free PMC article. Review.
Apoptosis in polycystic kidney disease.
Goilav B. Goilav B. Biochim Biophys Acta. 2011 Oct;1812(10):1272-80. doi: 10.1016/j.bbadis.2011.01.006. Epub 2011 Jan 15. Biochim Biophys Acta. 2011. PMID: 21241798 Free article. Review.
Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort.
Vazzana KM, Daga A, Goilav B, Ogbu EA, Okamura DM, Park C, Sadun RE, Smitherman EA, Stotter BR, Dasgupta A, Knight AM, Hersh AO, Wenderfer SE, Lewandowski LB; CARRA Registry investigators. Vazzana KM, et al. Among authors: goilav b. Lupus. 2021 Sep;30(10):1660-1670. doi: 10.1177/09612033211028658. Epub 2021 Jul 4. Lupus. 2021. PMID: 34219529 Free PMC article. Review.
58 results